Menu Back toSession 4: Adding Value to Ad Promo Review, Tips and Best Practices: Panel Discussion

Advertising and Promotion Regulatory Affairs Conference

This event is now offered in a new entirely virtual format.


Session 4: Adding Value to Ad Promo Review, Tips and Best Practices: Panel Discussion

Session Chair(s)

Victoria  Tamarkin, MS

Victoria Tamarkin, MS

  • Victoria Tamarkin Consulting LLC, United States
Join a mock Medical/Legal/Regulatory (MLR) panel as they walk participants through their strategies for Ad Promo review. Panelists will explore case studies and discuss best practices for reviewing materials for different audiences and settings such as in social media and in convention booths at scientific congresses. Participants will learn how the panel views complex topics such as evaluating and applying the appropriate evidentiary standards that guide the review of different types of materials. Lastly, the panel will share best practices for effectively managing conflicting points of view and in this way furthering the contribution of each review discipline as part of a well-functioning promotional review committee.
Learning Objective :
  • Understand the types of medical, legal and regulatory considerations that apply to different types of materials and audiences including FDA Guidance, where applicable
  • Gain confidence in knowing the types of questions that a reviewer will want to ask
  • Find themselves better equipped on how to manage tension/conflict in Promotional Review Committees (PRCs)
  • Learn practical tips to collaborate and add value within cross-functional MLR and Commercial teams

Speaker(s)

Danielle Asuncion Carreon, MPH

Speaker

Danielle Asuncion Carreon, MPH

  • Director, Regulatory Affairs
  • Bristol-Myers Squibb, United States
William  Aprea, JD

Speaker

William Aprea, JD

  • Executive Director, Senior Franchise and Compliance Counsel
  • (former) Bristol-Myers Squibb, United States
Richard  Gersh, MD

Speaker

Richard Gersh, MD

  • Executive Director, Global Medical Affairs
  • Merck, United States

Contact us